The FDA cleared EchoNext, the first artificial intelligence tool to detect structural heart disease before symptoms present.

Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some and turning deadly disease into a manageable chronic condition in others.

Olympic medalist Elana Meyers Taylor is the keynote speaker for this year's conference. Tickets are now on sale for the Horse Racing Women's Association conference, which returns to Lexington for the ...

Plus, Drexel’s biggest donation ever supports its new College of Engineering and Computing, winners at Penn Health-Tech Demo ...

Pathway Labs today announced its public launch of EchoNext, the world's first FDA-approved AI detection tool that reads standard 12-lead electrocardiograms (ECGs) to flag high risk structural heart ...

A quantum-inspired AI approach can analyze millions of molecular features from small datasets, improving predictions, ...

The Biomedical Informatics Graduate Program's aim is to educate and support the next generation of informatics leaders. Before you apply, learn more about our graduate programs and the benefits of ...

Explore the future of education with a focus on high-demand fields like AI, sustainability, and healthcare. Learn why Germany ...

AI tools designed to diagnose cancer from tissue samples are quietly learning more than just disease patterns. New research shows these systems can infer patient demographics from pathology slides, ...

CLF065, a long-acting, once-weekly GLP-2 receptor agonist, advances in two inflammatory bowel disease indications. The studies aim to bring a regenerative treatment option to patients living with IBD, ...